11.13 0.51(4.80%)09/13/2024
Astria Therapeutics Inc (ATXS)
Astria Therapeutics Inc (ATXS)
Showing latest 10 records. To view more news, Upgrade to PRO plan with only $1
| Headline | Time (ET) | Source |
|---|---|---|
| Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 09/04 16:10 | businesswire.com |
| Astria Therapeutics to Participate in Upcoming Morgan Stanley 22nd Annual Global Healthcare Conference | 08/29 08:00 | businesswire.com |
| Astria Therapeutics to Present at Upcoming Jefferies Healthcare Conference | 05/30 08:00 | businesswire.com |
| Astria Therapeutics to Present at Upcoming Eastern Allergy Conference | 05/24 08:00 | businesswire.com |
| Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress | 05/23 08:00 | businesswire.com |
| Astria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update | 05/09 16:10 | businesswire.com |
| Astria Therapeutics to Present at Upcoming Society for Investigative Dermatology Annual Meeting | 05/08 08:00 | businesswire.com |
| Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAE | 03/25 07:30 | businesswire.com |